These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 10392310)

  • 1. Role of CYP3A in haloperidol N-dealkylation and pharmacokinetics in rats.
    Watanabe M; Tateishi T; Asoh M; Nakura H; Tanaka M; Kumai T; Kobayashi S
    Fundam Clin Pharmacol; 1999; 13(3):337-42. PubMed ID: 10392310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of CYP3A in bromperidol metabolism in rat in vitro and in vivo.
    Watanabe M; Tateishi T; Tanaka M; Kumai T; Kobayashi S
    Xenobiotica; 1999 Aug; 29(8):839-46. PubMed ID: 10553724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the metabolism of haloperidol (HP): the role of CYP3A in the production of the neurotoxic pyridinium metabolite HPP+ found in rat brain following ip administration of HP.
    Igarashi K; Kasuya F; Fukui M; Usuki E; Castagnoli N
    Life Sci; 1995 Nov; 57(26):2439-46. PubMed ID: 8847965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formation in vitro of an inhibitory cytochrome P450 x Fe2+-metabolite complex with roxithromycin and its decladinosyl, O-dealkyl and N-demethyl metabolites in rat liver microsomes.
    Yamazaki H; Shimada T
    Xenobiotica; 1998 Oct; 28(10):995-1004. PubMed ID: 9849646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CYP3A is responsible for N-dealkylation of haloperidol and bromperidol and oxidation of their reduced forms by human liver microsomes.
    Tateishi T; Watanabe M; Kumai T; Tanaka M; Moriya H; Yamaguchi S; Satoh T; Kobayashi S
    Life Sci; 2000 Nov; 67(24):2913-20. PubMed ID: 11133003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid determination of rat hepatocyte mRNA induction potential using oligonucleotide probes for CYP1A1, 1A2, 3A and 4A1.
    Surry DD; Meneses-Lorente G; Heavens R; Jack A; Evans DC
    Xenobiotica; 2000 May; 30(5):441-56. PubMed ID: 10875679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of erythromycin and roxithromycin on oxidation of testosterone and nifedipine catalyzed by CYP3A4 in human liver microsomes.
    Yamazaki H; Urano T; Hiroki S; Shimada T
    J Toxicol Sci; 1996 Nov; 21(4):215-26. PubMed ID: 8959645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo antitumor activity and host toxicity of methoxymorpholinyl doxorubicin: role of cytochrome P450 3A.
    Quintieri L; Rosato A; Napoli E; Sola F; Geroni C; Floreani M; Zanovello P
    Cancer Res; 2000 Jun; 60(12):3232-8. PubMed ID: 10866316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-vitro characterization of the cytochrome P450 isoenzymes involved in the back oxidation and N-dealkylation of reduced haloperidol.
    Pan LP; De Vriendt C; Belpaire FM
    Pharmacogenetics; 1998 Oct; 8(5):383-9. PubMed ID: 9825830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. I. Cytochrome P-450-catalyzed N-demethylation and 4-hydroxylation.
    Mani C; Gelboin HV; Park SS; Pearce R; Parkinson A; Kupfer D
    Drug Metab Dispos; 1993; 21(4):645-56. PubMed ID: 8104124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolite complex formation of orphenadrine with cytochrome P450. Involvement of CYP2C11 and CYP3A isozymes.
    Roos PH; Mahnke A
    Biochem Pharmacol; 1996 Jul; 52(1):73-84. PubMed ID: 8678911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of human cytochrome P450 3A4 in reduced haloperidol oxidation.
    Kudo S; Odomi M
    Eur J Clin Pharmacol; 1998 May; 54(3):253-9. PubMed ID: 9681669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the conversion of haloperidol and its tetrahydropyridine dehydration product to potentially neurotoxic pyridinium metabolites by human liver microsomes.
    Usuki E; Pearce R; Parkinson A; Castagnol N
    Chem Res Toxicol; 1996 Jun; 9(4):800-6. PubMed ID: 8831826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Involvement of cytochrome P4503A in the monohydroxylation of ring A of praziquantel in rat liver microsomes].
    Zhang YJ; Quan YZ
    Yao Xue Xue Bao; 1997; 32(1):5-10. PubMed ID: 11243219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism of delavirdine, a human immunodeficiency virus type-1 reverse transcriptase inhibitor, by microsomal cytochrome P450 in humans, rats, and other species: probable involvement of CYP2D6 and CYP3A.
    Voorman RL; Maio SM; Hauer MJ; Sanders PE; Payne NA; Ackland MJ
    Drug Metab Dispos; 1998 Jul; 26(7):631-9. PubMed ID: 9660845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular non-genetic biomarkers of effect related to methyl thiophanate cocarcinogenesis: organ- and sex-specific cytochrome P450 induction in the rat.
    Paolini M; Pozzetti L; Perocco P; Mazzullo M; Cantelli-Forti G
    Cancer Lett; 1999 Jan; 135(2):203-13. PubMed ID: 10096430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro characterization of the oxidation of a pyridinium metabolite of haloperidol by human placenta: the effect of smoking.
    Fang J; Song J
    J Pharm Pharm Sci; 2012; 15(4):538-47. PubMed ID: 23106957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the contributions of CYP3A4 and CYP3A5 in the metabolism of the antipsychotic agent haloperidol to its potentially neurotoxic pyridinium metabolite and effect of antidepressants on the bioactivation pathway.
    Kalgutkar AS; Taylor TJ; Venkatakrishnan K; Isin EM
    Drug Metab Dispos; 2003 Mar; 31(3):243-9. PubMed ID: 12584149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microsomal oxidation of N,N-diethylformamide and its effect on P450-dependent monooxygenases in rat liver.
    Amato G; Longo V; Mazzaccaro A; Gervasi PG
    Chem Res Toxicol; 1996; 9(5):882-90. PubMed ID: 8828925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of monoclonal antibodies to cytochrome P450s to indicate the critical dealkylation and the P450s involved in methyl-n-amylnitrosamine mutagenicity in the presence of induced rat liver microsomes.
    Mirvish SS; Huang Q; Williamson J; Chen SC; Gelboin HV
    Mutat Res; 1995 Sep; 331(1):161-70. PubMed ID: 7666863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.